Listed

BioNexus Gene Lab Corp: Form 8-K, filed Oct 8, 2020

Filed with the SEC on Oct 8, 2020 and accepted by EDGAR at Oct 8, 2020, 15:32 ET.

Share

Items reported

  • Item 4.01 Change of auditor
  • Item 9.01 Financial statements and exhibits

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001477932-20-005798. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.